Compare OGN & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | ARCB |
|---|---|---|
| Founded | 1923 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.1B |
| IPO Year | 2020 | 1994 |
| Metric | OGN | ARCB |
|---|---|---|
| Price | $13.76 | $127.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $11.25 | ★ $166.85 |
| AVG Volume (30 Days) | ★ 2.0M | 154.6K |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.58% | 0.37% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $6,216,000,000.00 | $1,657,864,000.00 |
| Revenue This Year | N/A | $12.44 |
| Revenue Next Year | $2.51 | $7.93 |
| P/E Ratio | $14.48 | ★ N/A |
| Revenue Growth | N/A | ★ 12.56 |
| 52 Week Low | $5.69 | $59.43 |
| 52 Week High | $13.83 | $176.69 |
| Indicator | OGN | ARCB |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 42.37 |
| Support Level | $13.46 | $124.99 |
| Resistance Level | $13.77 | $135.48 |
| Average True Range (ATR) | 0.04 | 3.80 |
| MACD | -0.00 | 0.17 |
| Stochastic Oscillator | 34.78 | 28.72 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.